Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2025-01-05T12:42:38.850Z Has data issue: false hasContentIssue false
  • English
  • Français

High Dosage of Aripiprazole Induced Priapism: A Case Report

Published online by Cambridge University Press:  01 August 2011

Wen-Yu Hsu ,
Nan-Ying Chiu ,
Chieh-Hui Wang  and
Cheng-Yeh Lin
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editors
Information
CNS Spectrums , Volume 16 , Issue 8 , August 2011 , pp. 177
Copyright
Copyright © Cambridge University Press 2012

Footnotes

Faculty Disclosures: Dr. Hsu has received honoraria from Janssen-Cilag and Otuka; and has received funding from AstraZeneca, GlaxoSmithKline, and Sanofi-aventis; and he has participated in research collaboration with Janssen-Cilag, Lundbeck, MSD, and Otuka. Dr. Chiu has received honoraria from Eli Lilly, Janssen-Cilag, Otuka, Pfizer, and sanofi-aventis; has received funding from Otuka to attend scientific meetings; has participated in research collaboration with Janssen-Cilag, Lundbeck, MSD and Otuka. Dr. Wang has received honoraria from Eli Lilly, Janssen-Cilag, Pfizer, sanofi-aventis; has received funding from Otuka; and has participated in research collaboration with Janssen-Cilag, MSD, and Otuka. Dr. Lin reports no affiliations with or financial interests in any organization that may pose a conflict of interest.

References

Faculty Disclosures: Dr. Hsu has received honoraria from Janssen-Cilag and Otuka; and has received funding from AstraZeneca, GlaxoSmithKline, and Sanofi-aventis; and he has participated in research collaboration with Janssen-Cilag, Lundbeck, MSD, and Otuka. Dr. Chiu has received honoraria from Eli Lilly, Janssen-Cilag, Otuka, Pfizer, and sanofi-aventis; has received funding from Otuka to attend scientific meetings; has participated in research collaboration with Janssen-Cilag, Lundbeck, MSD and Otuka. Dr. Wang has received honoraria from Eli Lilly, Janssen-Cilag, Pfizer, sanofi-aventis; has received funding from Otuka; and has participated in research collaboration with Janssen-Cilag, MSD, and Otuka. Dr. Lin reports no affiliations with or financial interests in any organization that may pose a conflict of interest.